IN2013MU01157AIN1157MU2013AIN2013MU01157AIN 2013MU01157 AIN2013MU01157 AIN 2013MU01157AIN 1157MU2013 AIN1157MU2013 AIN 1157MU2013AIN 2013MU01157 AIN2013MU01157 AIN 2013MU01157A
Authority
IN
India
Prior art keywords
topiramate
salts
composition
pharmaceutical compositions
relates
Prior art date
Application number
Inventor
Girish Kumar Jain
Venkataramana Naidu
Atul Patil
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt LtdfiledCriticalWockhardt Ltd
Priority to IN1157MU2013priorityCriticalpatent/IN2013MU01157A/en
Priority to PCT/IB2014/060054prioritypatent/WO2014167439A1/en
Publication of IN2013MU01157ApublicationCriticalpatent/IN2013MU01157A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The present invention relates to pharmaceutical compositions of topiramate or salts thereof. In particular, the present invention relates to modified release pharmaceutical compositions comprising at least two types of components, wherein at least one type of the component comprises a matrix of topiramate or salts thereof and one or more release modifying substances. The composition may provide extended and specific release of topiramate or salts thereof to achieve therapeutically effective plasma concentration over a period of 24 hours to treat epileptic conditions when administered to a patient in need thereof. The invention also includes process of preparing such composition.
dihydro-6-azafenalene derivatives for the treatment of snc, oncological diseases and related disorders, pharmaceutical composition comprising them and use of said derivatives
Composition for treating or preventing diseases caused by vascular permeability, containing imatinib or pharmaceutically acceptable salt thereof as active ingredient.